Topic: Vaccine Education
Posted on 2/16/2021
Entercom Communications Corporation’s KCBS Radio San Francisco, Calif., discussed the issue of vaccine efficacy during its “Ask an Expert” segment on February 16. Dr. Cody Meissner, professor of pediatrics at Tufts Medical Center and member of the FDA advisory panel on vaccines, answered submitted questions from listeners and discussed the different reported efficacy rate of the Johnson & Johnson one-dose vaccine compared to the two-dose Pfizer and Moderna vaccines. Currently under the FDA approval process, Johnson & Johnson reported its one-dose vaccine is 66% protective against moderate to severe cases of COVID-19, compared to Pfizer’s 95% and Moderna’s 94% reported efficacy. "We’re seeing differences reported in the efficacy of different vaccines. But I think the very important point to remember is what we care most about is preventing severe illness, severe complications that result in intensive care admission or death, and I think all of the vaccines that are available are remarkably effective, they’re close to 100 percent in reducing death,” said Dr. Meissner. “All of these vaccines that have been evaluated so far show equal efficacy in preventing very severe disease.”
Read more stories on Vaccine Education »
More than 2.47 million American jobs depend on broadcasting, and the local broadcast radio and television industry - and the businesses that depend on it - generate $1.17 trillion annually for the nation's economy.
This site is brought to you by the National Association of Broadcasters. We advocate for the nation's radio and television broadcasters.
